🔎 Trials Near Me

Home › Oropharyngeal Cancer › New York › Queens

Oropharyngeal Cancer clinical trials in Queens, NY

5 studies for Oropharyngeal Cancer are looking for participants at sites in and around Queens (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

RecruitingPhase 2
  • NYU Langone Hospital - Long Island, Mineola · 11 mi away
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT05136196

A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat Cancer

RecruitingPhase 2
  • Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi away
Ages 18 and older · All sexes · Updated May 11, 2026 · NCT06984861

A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer

RecruitingPhase 2
  • Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi away
Ages 18 and older · All sexes · Updated Apr 23, 2026 · NCT05491512

A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)

RecruitingPhase 2
  • Memorial Sloan Kettering Nassau (Limited protocol activities), Rockville Centre · 10 mi away
Ages 18 and older · All sexes · Updated Apr 13, 2026 · NCT05307939

A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)

RecruitingPhase 2
  • Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi away
Ages 18 and older · All sexes · Updated Feb 19, 2026 · NCT07063212

Oropharyngeal Cancer trials in other cities

Other studies in Queens

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.